People with an altered release of the stress hormone cortisol have an increased risk of dying from cardiovascular disease. Researchers reported this in the journal Psychoneuroimmunology. According to the study, it is essential to assess the risk by looking at the daily profile of...

Read more

Atherosclerosis and the resulting secondary diseases, coronary heart disease (CHD) and myocardial infarction (MI) are the leading causes of death worldwide. Despite intensive research, it is still unclear why this disease can be inherited. Under the leadership of Prof. Dr....

Read more

At its spring meetings, the German Science Council rated the Center for Cardiovascular Disease Control (CCDC) proposed by the Mannheim Medical Faculty of Heidelberg University as "very good to outstanding" and recommended it for funding. The research building at the DZHK partner...

Read more

LMU scientists have been able to demonstrate for the first time that nerve signals are exchanged between arteries and the brain in atherosclerosis.

Read more

Congratulations! At the 88th annual conference of the German Society for Cardiology - Cardiovascular Research e. V. (DGK), numerous DZHK scientists received awards.

Read more

Outstanding researchers from the DZHK receive the renowned ERC Advanced Grant 2022.

Read more

Scientists show in the animal model that the messenger CXCL12 could be suitable as a target structure for the therapy of blood clotting disorders.

Read more

So far, there are only a few medicines for heart failure patients with cardiac arrhythmias. Those that are approved often have severe side effects. Scientists have uncovered a mechanism that leads to arrhythmias. In the animal model, they succeeded in switching off the mechanism....

Read more

DZHK Board Spokesperson Prof. Dr. Stefanie Dimmeler has been awarded with the Otto Warburg Medal of the Society for Biochemistry and Molecular Biology for her groundbreaking work in the field of cardiovascular diseases.

Read more